Methylation among members of the PI3K/AKT/mTOR pathway in melanoma brain and extracerebral metastases

被引：0
|
作者：
Meier, Friedegund Elke
Westphal, Dana
Meinhardt, Matthias
Gruetzmann, Konrad
Schrimpf, Daniel
Aust, Daniela Ellen
Schroeck, Evelin
Baretton, Gustavo Bruno
Beissert, Stefan
Schackert, Gabriele
von Deimling, Andreas
Koelsche, Christian
Klink, Barbara
Muders, Michael
Seifert, Michael
机构：
[1] Univ Klinikum Carl Gustav Carus, Dresden, Germany
[2] Tech Univ Dresden, Dept Dermatol, Carl Gustav Carus Med Ctr, Oncol, Dresden, Germany
[3] Tech Univ Dresden, Inst Pathol, Fac Med, Dresden, Germany
[4] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dresden, Germany
[5] Partner Site Dresden, Natl Ctr Tumor Dis NCT, Dresden, Germany
[6] Univ Heidelberg Hosp, Inst Pathol, Dept Neuropathol, Heidelberg, Germany
[7] Tech Univ Dresden, Inst Clin Genet, Dresden, Germany
[8] Tech Univ Dresden, Dept Dermatol, Carl Gustav Carus Med Ctr, Dresden, Germany
[9] Univ Hosp Dresden, Dept Neurosurg, Dresden, Germany
[10] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany
[11] Univ Heidelberg Hosp, Dept Neuropathol, Heidelberg, Germany
[12] Tech Univ Dresden, Inst Med Informat & Biometry, Fac Med, Dresden, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21515
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21515
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Members of the PI3K/AKT/mTOR Signaling Pathway are differentially methylated and expressed in intra- and extracerebral Melanoma Metastases
    Westphal, D.
    Meinhardt, M.
    Gruetzmann, K.
    Schrimpf, D.
    Aust, D.
    Schroeck, E.
    Baretton, G.
    Beissert, S.
    Schackert, G.
    von Deimling, A.
    Koelsche, C.
    Klink, B.
    Muders, M.
    Seifert, M.
    Meier, F.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 8 - 8
  • [2] The PI3K/Akt/mTOR pathway as a preventive target in melanoma brain metastasis
    Tehranian, Cedric
    Fankhauser, Laura
    Harter, Patrick N.
    Ratcliffe, Colin D. H.
    Zeiner, Pia S.
    Messmer, Julia M.
    Hoffmann, Dirk C.
    Frey, Katharina
    Westphal, Dana
    Ronellenfitsch, Michael W.
    Sahai, Erik
    Wick, Wolfgang
    Karreman, Matthia A.
    Winkler, Frank
    NEURO-ONCOLOGY, 2022, 24 (02) : 213 - 225
  • [3] PI3K/AKT/mTOR pathway in angiogenesis
    Karar, Jayashree
    Maity, Amit
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2011, 4
  • [4] The PI3K/Akt/mTOR signaling pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2011, 22 : 19 - 19
  • [5] Overview of the PI3K/Akt/mTOR pathway
    Dennis, P. A.
    ANNALS OF ONCOLOGY, 2008, 19 : 21 - 21
  • [6] The PI3K/AKT/mTOR interactive pathway
    Ersahin, Tulin
    Tuncbag, Nurcan
    Cetin-Atalay, Rengul
    MOLECULAR BIOSYSTEMS, 2015, 11 (07) : 1946 - 1954
  • [7] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [8] RAS Signaling in the PI3K/AKT/MTOR Pathway
    Nussinov, Ruth
    Zhang, Mingzhen
    Jang, Hyunbum
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 51A - 51A
  • [9] THE PI3K/AKT MTOR PATHWAY IN OLIGODENDROCYTE DIFFERENTIATION
    Wood, T.
    Tyler, W.
    Gangoli, N.
    Gokina, P.
    Kim, H.
    Covey, M.
    Levison, S.
    GLIA, 2009, 57 (13) : S20 - S20
  • [10] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
12345